- CNBC•2 years ago
Novavax shares rose at Tuesday's market open after the bio-pharmaceutical firm said its Ebola vaccine showed promising early results.
- Motley Fool•2 years ago
Investing in biotech may look easy, but make this mistake and it could wind up costing you dearly.
- Investor's Business Daily•2 years ago
The new class of hepatitis C drugs, led by Gilead Sciences (GILD) and AbbVie (ABBV), has turned into one of the biggest success stories in biotech history. Yet hepatitis C is one of only five viruses that ...
TKMR : Summary for Arbutus Biopharma Corporation - Yahoo Finance
Tekmira Pharmaceuticals Corporation (TKMR)
NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
|Bid||2.50 x 4200|
|Ask||2.55 x 2100|
|Day's Range||2.35 - 2.55|
|52 Week Range||2.35 - 11.03|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-1.88|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|